Chandra Nohria Family Chair for AI in Cancer Research;
Chief
Division of Population Sciences
Dana-Farber Cancer Institute;
Professor of Medicine
Harvard Medical School
Boston, MA;
Institute Member
Broad Institute of MIT and Harvard
Cambridge, Massachusetts
For pioneering discoveries advancing precision oncology through the integration of cancer genomics and computational biology to identify molecular determinants of therapeutic response and resistance. Dr. Van Allen’s research has defined genomic mechanisms underlying resistance to targeted therapies, including BRAF inhibition in melanoma, and identified genomic features associated with response to immune checkpoint blockade through large-scale tumor sequencing and integrative genomic analyses. His work has advanced biomarker discovery and the use of genomic data to guide personalized cancer treatment.
In 2017, the AACR instituted the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research to recognize a worthy cancer researcher who has conducted highly meritorious translational and clinical cancer research anywhere in the world, and who has not yet reached 51 years of age at the time of award presentation. The award was established in recognition of the extraordinary contributions that Hong, a Fellow of the AACR Academy, made to advances in cancer research, cancer care, and cancer prevention during his long-standing and brilliant career as a physician-scientist. To learn more, please visit the press release.
View Past Recipients.